Evidence map›Paper›PMID 42460112›Full record

ArticleClinical case reports2026

Prenatal Fetal Growth Restriction and Cardiomyopathy Associated With an Unbalanced der(15)t(7;15): A Case Report.

Yoko Nagayasu, Nagisa Ishikawa, Seiichiro Nao, Atsushi Yoshida, Hiroshi Ohta, Misa Nunode, Mayumi Nakamura, Takumi Sano, Masae Yoo, Yutaka Odanaka and 2 more

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yoko NagayasuDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Nagisa IshikawaDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Seiichiro NaoDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Atsushi YoshidaDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Hiroshi OhtaDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Misa NunodeDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Mayumi NakamuraDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Takumi SanoDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Masae YooDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Yutaka OdanakaDepartment of Pediatrics Osaka Medical and Pharmaceutical University Osaka Japan.
Daisuke FujitaDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.
Tomohito TanakaDepartment of Obstetrics and Gynecology Osaka Medical and Pharmaceutical University Osaka Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe fetal growth restriction with cardiomyopathy may indicate an underlying chromosomal abnormality. Genetic evaluation is essential for accurate counseling and management, and preimplantation genetic testing for structural rearrangements (PGT-SR) may be considered for future reproductive planning.

Indexed as

15q26 deletionchromosomal translocationfetal cardiomyopathyfetal growth restriction(FGR)preimplantation genetic testing for structural rearrangements (PGT‐SR)

Identifiers

PMID42460112
PMCPMC13368701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.